Kristian Gaarn du Jardin, Heidi Kaastrup Müller, Betina Elfving, Elena Dale, Gregers Wegener, Connie Sanchez. Prog Neuropsychopharmacol Biol Psychiatry 2016
Times Cited: 36
Times Cited: 36
Times Cited
Times Co-cited
Similarity
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
55
Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
50
NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
30
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.
C Yang, Y Shirayama, J-c Zhang, Q Ren, W Yao, M Ma, C Dong, K Hashimoto. Transl Psychiatry 2015
C Yang, Y Shirayama, J-c Zhang, Q Ren, W Yao, M Ma, C Dong, K Hashimoto. Transl Psychiatry 2015
30
Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
T H Pham, I Mendez-David, C Defaix, B P Guiard, L Tritschler, D J David, A M Gardier. Neuropharmacology 2017
T H Pham, I Mendez-David, C Defaix, B P Guiard, L Tritschler, D J David, A M Gardier. Neuropharmacology 2017
30
Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.
James W Murrough, Andrew M Perez, Sarah Pillemer, Jessica Stern, Michael K Parides, Marije aan het Rot, Katherine A Collins, Sanjay J Mathew, Dennis S Charney, Dan V Iosifescu. Biol Psychiatry 2013
James W Murrough, Andrew M Perez, Sarah Pillemer, Jessica Stern, Michael K Parides, Marije aan het Rot, Katherine A Collins, Sanjay J Mathew, Dennis S Charney, Dan V Iosifescu. Biol Psychiatry 2013
27
Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism.
Valentina Gigliucci, Grainne O'Dowd, Sheena Casey, Danielle Egan, Sinead Gibney, Andrew Harkin. Psychopharmacology (Berl) 2013
Valentina Gigliucci, Grainne O'Dowd, Sheena Casey, Danielle Egan, Sinead Gibney, Andrew Harkin. Psychopharmacology (Berl) 2013
25
mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
22
A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques.
H Yamanaka, C Yokoyama, H Mizuma, S Kurai, S J Finnema, C Halldin, H Doi, H Onoe. Transl Psychiatry 2014
H Yamanaka, C Yokoyama, H Mizuma, S Kurai, S J Finnema, C Halldin, H Doi, H Onoe. Transl Psychiatry 2014
19
The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN.
Kenichi Fukumoto, Michihiko Iijima, Shigeyuki Chaki. Neuropsychopharmacology 2016
Kenichi Fukumoto, Michihiko Iijima, Shigeyuki Chaki. Neuropsychopharmacology 2016
19
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
D Jeffrey Newport, Linda L Carpenter, William M McDonald, James B Potash, Mauricio Tohen, Charles B Nemeroff. Am J Psychiatry 2015
D Jeffrey Newport, Linda L Carpenter, William M McDonald, James B Potash, Mauricio Tohen, Charles B Nemeroff. Am J Psychiatry 2015
19
R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine.
Ji-Chun Zhang, Su-Xia Li, Kenji Hashimoto. Pharmacol Biochem Behav 2014
Ji-Chun Zhang, Su-Xia Li, Kenji Hashimoto. Pharmacol Biochem Behav 2014
19
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
19
19
Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.
Kristian Gaarn du Jardin, Nico Liebenberg, Heidi Kaastrup Müller, Betina Elfving, Connie Sanchez, Gregers Wegener. Psychopharmacology (Berl) 2016
Kristian Gaarn du Jardin, Nico Liebenberg, Heidi Kaastrup Müller, Betina Elfving, Connie Sanchez, Gregers Wegener. Psychopharmacology (Berl) 2016
16
Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
Hiroyuki Koike, Michihiko Iijima, Shigeyuki Chaki. Behav Brain Res 2011
Hiroyuki Koike, Michihiko Iijima, Shigeyuki Chaki. Behav Brain Res 2011
16
Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine.
Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, Takashi Hashihayata, Jun-Ichi Yamaguchi, Kenji Hashimoto, Shigeyuki Chaki. J Pharmacol Exp Ther 2017
Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, Takashi Hashihayata, Jun-Ichi Yamaguchi, Kenji Hashimoto, Shigeyuki Chaki. J Pharmacol Exp Ther 2017
16
Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
Sungho Maeng, Carlos A Zarate, Jing Du, Robert J Schloesser, Joseph McCammon, Guang Chen, Husseini K Manji. Biol Psychiatry 2008
Sungho Maeng, Carlos A Zarate, Jing Du, Robert J Schloesser, Joseph McCammon, Guang Chen, Husseini K Manji. Biol Psychiatry 2008
16
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
James W Murrough, Dan V Iosifescu, Lee C Chang, Rayan K Al Jurdi, Charles E Green, Andrew M Perez, Syed Iqbal, Sarah Pillemer, Alexandra Foulkes, Asim Shah,[...]. Am J Psychiatry 2013
James W Murrough, Dan V Iosifescu, Lee C Chang, Rayan K Al Jurdi, Charles E Green, Andrew M Perez, Syed Iqbal, Sarah Pillemer, Alexandra Foulkes, Asim Shah,[...]. Am J Psychiatry 2013
16
GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine.
Oliver H Miller, Lingling Yang, Chih-Chieh Wang, Elizabeth A Hargroder, Yihui Zhang, Eric Delpire, Benjamin J Hall. Elife 2014
Oliver H Miller, Lingling Yang, Chih-Chieh Wang, Elizabeth A Hargroder, Yihui Zhang, Eric Delpire, Benjamin J Hall. Elife 2014
16
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression.
Paulo R Shiroma, Brian Johns, Michael Kuskowski, Joseph Wels, Paul Thuras, C Sophia Albott, Kelvin O Lim. J Affect Disord 2014
Paulo R Shiroma, Brian Johns, Michael Kuskowski, Joseph Wels, Paul Thuras, C Sophia Albott, Kelvin O Lim. J Affect Disord 2014
13
Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.
Chadi G Abdallah, Gerard Sanacora, Ronald S Duman, John H Krystal. Annu Rev Med 2015
Chadi G Abdallah, Gerard Sanacora, Ronald S Duman, John H Krystal. Annu Rev Med 2015
13
Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex.
Naoya Nishitani, Kazuki Nagayasu, Nozomi Asaoka, Mayumi Yamashiro, Hisashi Shirakawa, Takayuki Nakagawa, Shuji Kaneko. Int J Neuropsychopharmacol 2014
Naoya Nishitani, Kazuki Nagayasu, Nozomi Asaoka, Mayumi Yamashiro, Hisashi Shirakawa, Takayuki Nakagawa, Shuji Kaneko. Int J Neuropsychopharmacol 2014
13
Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.
Kenichi Fukumoto, Michihiko Iijima, Shigeyuki Chaki. Psychopharmacology (Berl) 2014
Kenichi Fukumoto, Michihiko Iijima, Shigeyuki Chaki. Psychopharmacology (Berl) 2014
13
Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
Nanxin Li, Rong-Jian Liu, Jason M Dwyer, Mounira Banasr, Boyoung Lee, Hyeon Son, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Biol Psychiatry 2011
Nanxin Li, Rong-Jian Liu, Jason M Dwyer, Mounira Banasr, Boyoung Lee, Hyeon Son, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Biol Psychiatry 2011
13
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants.
Caroline A Browne, Irwin Lucki. Front Pharmacol 2013
Caroline A Browne, Irwin Lucki. Front Pharmacol 2013
13
NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice.
Adam K Walker, David P Budac, Stephanie Bisulco, Anna W Lee, Robin A Smith, Brent Beenders, Keith W Kelley, Robert Dantzer. Neuropsychopharmacology 2013
Adam K Walker, David P Budac, Stephanie Bisulco, Anna W Lee, Robin A Smith, Brent Beenders, Keith W Kelley, Robert Dantzer. Neuropsychopharmacology 2013
13
The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders.
M Kokkinou, A H Ashok, O D Howes. Mol Psychiatry 2018
M Kokkinou, A H Ashok, O D Howes. Mol Psychiatry 2018
13
Signaling pathways underlying the rapid antidepressant actions of ketamine.
Ronald S Duman, Nanxin Li, Rong-Jian Liu, Vanja Duric, George Aghajanian. Neuropharmacology 2012
Ronald S Duman, Nanxin Li, Rong-Jian Liu, Vanja Duric, George Aghajanian. Neuropharmacology 2012
11
Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.
Marije aan het Rot, Katherine A Collins, James W Murrough, Andrew M Perez, David L Reich, Dennis S Charney, Sanjay J Mathew. Biol Psychiatry 2010
Marije aan het Rot, Katherine A Collins, James W Murrough, Andrew M Perez, David L Reich, Dennis S Charney, Sanjay J Mathew. Biol Psychiatry 2010
11
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
C L Raison, R Dantzer, K W Kelley, M A Lawson, B J Woolwine, G Vogt, J R Spivey, K Saito, A H Miller. Mol Psychiatry 2010
C L Raison, R Dantzer, K W Kelley, M A Lawson, B J Woolwine, G Vogt, J R Spivey, K Saito, A H Miller. Mol Psychiatry 2010
11
Nitric oxide involvement in the antidepressant-like effect of ketamine in the Flinders sensitive line rat model of depression.
Nico Liebenberg, Sâmia Joca, Gregers Wegener. Acta Neuropsychiatr 2015
Nico Liebenberg, Sâmia Joca, Gregers Wegener. Acta Neuropsychiatr 2015
11
Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.
Shigeyuki Yamamoto, Hiroyuki Ohba, Shingo Nishiyama, Norihiro Harada, Takeharu Kakiuchi, Hideo Tsukada, Edward F Domino. Neuropsychopharmacology 2013
Shigeyuki Yamamoto, Hiroyuki Ohba, Shingo Nishiyama, Norihiro Harada, Takeharu Kakiuchi, Hideo Tsukada, Edward F Domino. Neuropsychopharmacology 2013
11
Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.
Carlos A Zarate, Nancy Brutsche, Gonzalo Laje, David A Luckenbaugh, Swarajya L Vattem Venkata, Anuradha Ramamoorthy, Ruin Moaddel, Irving W Wainer. Biol Psychiatry 2012
Carlos A Zarate, Nancy Brutsche, Gonzalo Laje, David A Luckenbaugh, Swarajya L Vattem Venkata, Anuradha Ramamoorthy, Ruin Moaddel, Irving W Wainer. Biol Psychiatry 2012
11
Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.
T Kishimoto, J M Chawla, K Hagi, C A Zarate, J M Kane, M Bauer, C U Correll. Psychol Med 2016
T Kishimoto, J M Chawla, K Hagi, C A Zarate, J M Kane, M Bauer, C U Correll. Psychol Med 2016
11
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
11
Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model.
Chun Yang, Qian Ren, Youge Qu, Ji-Chun Zhang, Min Ma, Chao Dong, Kenji Hashimoto. Biol Psychiatry 2018
Chun Yang, Qian Ren, Youge Qu, Ji-Chun Zhang, Min Ma, Chao Dong, Kenji Hashimoto. Biol Psychiatry 2018
11
GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.
Jeffrey Burgdorf, Xiao-lei Zhang, Katherine L Nicholson, Robert L Balster, J David Leander, Patric K Stanton, Amanda L Gross, Roger A Kroes, Joseph R Moskal. Neuropsychopharmacology 2013
Jeffrey Burgdorf, Xiao-lei Zhang, Katherine L Nicholson, Robert L Balster, J David Leander, Patric K Stanton, Amanda L Gross, Roger A Kroes, Joseph R Moskal. Neuropsychopharmacology 2013
11
Glutamate-based antidepressants: 20 years on.
Phil Skolnick, Piotr Popik, Ramon Trullas. Trends Pharmacol Sci 2009
Phil Skolnick, Piotr Popik, Ramon Trullas. Trends Pharmacol Sci 2009
11
A randomized controlled trial of intranasal ketamine in major depressive disorder.
Kyle A B Lapidus, Cara F Levitch, Andrew M Perez, Jess W Brallier, Michael K Parides, Laili Soleimani, Adriana Feder, Dan V Iosifescu, Dennis S Charney, James W Murrough. Biol Psychiatry 2014
Kyle A B Lapidus, Cara F Levitch, Andrew M Perez, Jess W Brallier, Michael K Parides, Laili Soleimani, Adriana Feder, Dan V Iosifescu, Dennis S Charney, James W Murrough. Biol Psychiatry 2014
11
Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
Adriana Feder, Michael K Parides, James W Murrough, Andrew M Perez, Julia E Morgan, Shireen Saxena, Katherine Kirkwood, Marije Aan Het Rot, Kyle A B Lapidus, Le-Ben Wan,[...]. JAMA Psychiatry 2014
Adriana Feder, Michael K Parides, James W Murrough, Andrew M Perez, Julia E Morgan, Shireen Saxena, Katherine Kirkwood, Marije Aan Het Rot, Kyle A B Lapidus, Le-Ben Wan,[...]. JAMA Psychiatry 2014
11
Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.
Rebecca B Price, Dan V Iosifescu, James W Murrough, Lee C Chang, Rayan K Al Jurdi, Syed Z Iqbal, Laili Soleimani, Dennis S Charney, Alexandra L Foulkes, Sanjay J Mathew. Depress Anxiety 2014
Rebecca B Price, Dan V Iosifescu, James W Murrough, Lee C Chang, Rayan K Al Jurdi, Syed Z Iqbal, Laili Soleimani, Dennis S Charney, Alexandra L Foulkes, Sanjay J Mathew. Depress Anxiety 2014
11
Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.
Ying Xu, Maree Hackett, Gregory Carter, Colleen Loo, Verònica Gálvez, Nick Glozier, Paul Glue, Kyle Lapidus, Alexander McGirr, Andrew A Somogyi,[...]. Int J Neuropsychopharmacol 2016
Ying Xu, Maree Hackett, Gregory Carter, Colleen Loo, Verònica Gálvez, Nick Glozier, Paul Glue, Kyle Lapidus, Alexander McGirr, Andrew A Somogyi,[...]. Int J Neuropsychopharmacol 2016
11
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
Samuel T Wilkinson, Elizabeth D Ballard, Michael H Bloch, Sanjay J Mathew, James W Murrough, Adriana Feder, Peter Sos, Gang Wang, Carlos A Zarate, Gerard Sanacora. Am J Psychiatry 2018
Samuel T Wilkinson, Elizabeth D Ballard, Michael H Bloch, Sanjay J Mathew, James W Murrough, Adriana Feder, Peter Sos, Gang Wang, Carlos A Zarate, Gerard Sanacora. Am J Psychiatry 2018
11
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.
Nolan R Williams, Boris D Heifets, Christine Blasey, Keith Sudheimer, Jaspreet Pannu, Heather Pankow, Jessica Hawkins, Justin Birnbaum, David M Lyons, Carolyn I Rodriguez,[...]. Am J Psychiatry 2018
Nolan R Williams, Boris D Heifets, Christine Blasey, Keith Sudheimer, Jaspreet Pannu, Heather Pankow, Jessica Hawkins, Justin Birnbaum, David M Lyons, Carolyn I Rodriguez,[...]. Am J Psychiatry 2018
11
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites.
Chun Yang, Jianjun Yang, Ailin Luo, Kenji Hashimoto. Transl Psychiatry 2019
Chun Yang, Jianjun Yang, Ailin Luo, Kenji Hashimoto. Transl Psychiatry 2019
11
A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Marie Naughton, Gerard Clarke, Olivia F O'Leary, John F Cryan, Timothy G Dinan. J Affect Disord 2014
Marie Naughton, Gerard Clarke, Olivia F O'Leary, John F Cryan, Timothy G Dinan. J Affect Disord 2014
8
Behavioural despair in rats: a new model sensitive to antidepressant treatments.
R D Porsolt, G Anton, N Blavet, M Jalfre. Eur J Pharmacol 1978
R D Porsolt, G Anton, N Blavet, M Jalfre. Eur J Pharmacol 1978
8
Treatment-resistant depression: are animal models of depression fit for purpose?
Paul Willner, Catherine Belzung. Psychopharmacology (Berl) 2015
Paul Willner, Catherine Belzung. Psychopharmacology (Berl) 2015
8
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.